Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Bonvento

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Neurobiology of Disease|May 21, 2021
THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiencyAudrey Vautheny, Charlotte Duwat, Gwennaëlle Aurégan, et al.
Neurobiology of Disease|April 13, 2023
Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathologyCharlotte Duwat, Pauline Léal, Audrey Vautheny, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2015
The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseasesLucile Ben Haim, Kelly Ceyzériat, Maria Angeles Carrillo-de Sauvage, et al.
Neurobiology of Aging|March 16, 2020
Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer diseaseOcéane Guillemaud, Kelly Ceyzériat, Thomas Saint-Georges, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 19, 2014
Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactionsLydie Boussicault, Anne-Sophie Hérard, Noel Calingasan, et al.
Science Translational Medicine|April 7, 2010
Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesiaBéchir Jarraya, Sabrina Boulet, G Scott Ralph, et al.
Neurobiology of Disease|October 13, 2019
The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivoNoémie Cresto, Marie-Claude Gaillard, Camille Gardier, et al.
Molecular Psychiatry|July 23, 2025
Upregulation of adenosine A<sub>2A</sub> receptor in astrocytes is sufficient to trigger hippocampal multicellular dysfunctions and memory deficitsAgathe Launay, Kevin Carvalho, Athénais Genin, et al.
Glia|March 22, 2025
Hippocampal Astrocyte Morphology Follows an Unexpected Trajectory With Age in a Transgenic Rodent Model of TauopathyEmma Augustin, Tatiana Vinasco-Sandoval, Miriam Riquelme-Perez, et al.
Brain : a Journal of Neurology|April 12, 2021
Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation stateAnastasie Maté de Gérando, Marie d'Orange, Emma Augustin, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Neurobiology of Disease|May 21, 2021
THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiencyAudrey Vautheny, Charlotte Duwat, Gwennaëlle Aurégan, et al.
Neurobiology of Disease|April 13, 2023
Development of an AAV-based model of tauopathy targeting retinal ganglion cells and the mouse visual pathway to study the role of microglia in Tau pathologyCharlotte Duwat, Pauline Léal, Audrey Vautheny, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2015
The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer's and Huntington's diseasesLucile Ben Haim, Kelly Ceyzériat, Maria Angeles Carrillo-de Sauvage, et al.
Neurobiology of Aging|March 16, 2020
Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer diseaseOcéane Guillemaud, Kelly Ceyzériat, Thomas Saint-Georges, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 19, 2014
Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactionsLydie Boussicault, Anne-Sophie Hérard, Noel Calingasan, et al.
Science Translational Medicine|April 7, 2010
Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesiaBéchir Jarraya, Sabrina Boulet, G Scott Ralph, et al.
Neurobiology of Disease|October 13, 2019
The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivoNoémie Cresto, Marie-Claude Gaillard, Camille Gardier, et al.
Molecular Psychiatry|July 23, 2025
Upregulation of adenosine A<sub>2A</sub> receptor in astrocytes is sufficient to trigger hippocampal multicellular dysfunctions and memory deficitsAgathe Launay, Kevin Carvalho, Athénais Genin, et al.
Glia|March 22, 2025
Hippocampal Astrocyte Morphology Follows an Unexpected Trajectory With Age in a Transgenic Rodent Model of TauopathyEmma Augustin, Tatiana Vinasco-Sandoval, Miriam Riquelme-Perez, et al.
Brain : a Journal of Neurology|April 12, 2021
Neuronal tau species transfer to astrocytes and induce their loss according to tau aggregation stateAnastasie Maté de Gérando, Marie d'Orange, Emma Augustin, et al.
Pageof 8